Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

EncrypGen is Growing the Gene-Chain Marketplace with viazoi Partnership

Viazoi Kits can be Purchased in EncrypGen's Gene-Chain Marketplace; Enhancing the Way People Store, Own and Use Genetic Data for Personal Wellness


News provided by

EncrypGen

Jan 16, 2019, 04:55 ET

Share this article

Share toX

Share this article

Share toX

viazoi
viazoi

LEWES, Del., Jan. 16, 2019 /PRNewswire-PRWeb/ -- As the New Year is upon us and health and wellness are at the top of most people's minds; EncrypGen kicks off the year with a new viazoi partnership that will serve health minded individuals and the scientific community alike. People who want to gain insights about their own unique biology to help manage their wellness may now buy viazoi test kits in the Gene-Chain Marketplace.

A division of Foundation Laboratory, viazoi, is a leader for at-home wellness testing providing people with actionable biological insights that supports their personal wellness journey. EncrypGen adding a partner like viazoi goes hand-and-hand with the company's core values of data privacy and control allowing customers to profit by DNA cryptocurrency if they want to sell their data to scientist or researchers.

We are extremely proud to become partners with viazoi to help their customers control and even monetize their data. We are including their products in our marketplace and tests can be bought with DNA tokens or PayPal.

Post this

"For the first time in history, the average person has affordable and direct access to the biology within them, from genes to gut microbes and proteins. This information can help an individual when making choices for overall well-being," states President of viazoi, Evangeline Gonzalez. "Viazoi is dedicated to making this information affordable and understandable in such a way that it can have a real impact on a person's life and daily choices."

As a Gene-Chain Marketplace partner, viazoi easily enables health minded individuals by providing a suite of products that can help them manage their personal wellness and secure their genomic data, and in addition, viazoi testing kits may be purchased with DNA tokens, yet another use case for spending the cryptocurrency.

How will this partnership impact individuals making decisions for their overall well-being, health and controlling their data? Here are a few ways:

*First, viazoi translates biological results into customized programs, unique to each person due to the company believing the first step in wellness is information. It's the combination of life choices and a person's genetic code that makes up their unique biology...their U-ology™.

*Second, viazoi's tests and analysis assist people to make more informed choices about what food they eat, health products they use, types and amounts of exercise they do, and more. All of which can significantly improve the outcomes of wellness goals.

*Third, viazoi simplifies the process of DNA testing by providing an easy, at-home genetic test that only requires a simple cheek swab.

*Ownership and control of genomic data is where the EncrypGen partnership comes full-circle by empowering customers to buy viazoi at-home test kits with DNA tokens, securely uploading their test results and having them indexed on EncrypGen's Gene-Chain platform.

*Finally, Individuals who decide to share their data with scientists and researchers to help find better treatments and cures for diseases can start earning Encrygen's DNA tokens for selling their de-identified genomic data in the Gene-Chain Marketplace.

"When viazoi reached out to us, it was clear they shared our point of view about data ownership and individual empowerment. We are excited to add their services to our customer marketplace and looking forward to accommodating their testing customers into our Gene-Chain," explains CEO and Co-Founder of EncrypGen, David Koepsell, J.D., Ph.D. "We are extremely proud to become partners with viazoi to help their customers control and even monetize their data. We are including their products in our marketplace and tests can be bought with DNA tokens or PayPal."

"Collaborations and partnerships such as viazoi and EncrypGen are essential to not only the individual who benefits from learning about their body in order to realize their wellness goals but also allowing the scientific community to have access to pooled anonymous data which will really accelerate the greater understanding of how to age gracefully," comments Steve Jordan, (BS, CSCS, CES, PES, CPT, HLC) an advocate for health and wellness for viazoi. "This is great for both the individuals but also for society. It is the future."

For those interested in buying a vazoi Kit via PayPal or with DNA tokens then uploading their data via EncrypGen can do so by clicking here.

About viazoi:

A division of Foundation Laboratory, viazoi, a CLIA certified diagnostic testing laboratory that has been in business for over 6 decades. With the desire to expand from providing just laboratory results for medical institutions focused on disease, Foundation Laboratory formed a new division called viazoi, whose meaning in Latin and Greek is "Through Life". Viazoi creates wellness programs that translates biological data into actionable results that can have a real impact on a person's life and daily choices to support their wellness journey. Follow viazoi socials here: Instagram, Facebook, Twitter, LinkedIn, YouTube.

About EncrypGen:

EncrypGen creates software (The Gene-Chain) that empowers consumers, researchers, and businesses to share genetic data with one another using a blockchain for enhanced privacy and security while paying each other with the DNA token. Husband and wife team, Dr. Vanessa Gonzalez Covarrubias and Dr. David Koepsell founded the company in December 2016. Dr. Covarrubias is a genomic scientist, and Dr. Koepsell is a philosopher, lawyer and author who both wanted to leverage blockchain technology to provide greater privacy for the sharing of genomic data for individuals, and to give them a means to sell their data, and at the same time make more data available for scientists. Follow EncrypGen via socials here: Facebook, Twitter, YouTube, LinkedIn, Telegram, Discord, Reddit.

SOURCE EncrypGen

Related Links

http://www.encrypgen.com

Modal title

Gene-Chain Marketplace
Gene-Chain Marketplace
EncrypGen Partners
EncrypGen Partners
Gene-Chain Marketplace
Gene-Chain Marketplace
EncrypGen
EncrypGen
Gene-Chain Marketplace EncrypGen Partners Gene-Chain Marketplace EncrypGen

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.